Discovering a Common Goal,
Discovering a Cure


Research News
Drug News
Conference News
< Home

Startup Brings $217 Million to Neurodegenerative Disease Research
May 15, 2015

Denali Therapeutics, a new biotechnology company in South San Francisco, today announced its start with an initial $217 million of venture capital (see 

MRF and NIH Launch Clinical Testing of Guanabenz in Multiple Sclerosis
May 14, 2015

Multiple sclerosis (MS) is a disease in which the immune systems attacks myelin surrounding axons in the central nervous system, leading to impaired neurotransmission and progressive axonal degeneration. Currently approved treatments for MS...

MJFF Partners with Imago Pharmaceuticals to Study Parkin Protein
May 14, 2015

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has acquired research tools from Imago Pharmaceuticals (originally developed by Elan Pharmaceuticals) to accelerate research and drug...

USC, Sanofi and DRVision Partner to Identify New Candidate ALS Drugs
May 11, 2015

A new partnership between University of Southern California (USC), Sanofi, and startup company DRVision Technologies, with funding from the...

Transthyretin Shows Promise as Biomarker for C9ORF72 ALS and FTD
May 7, 2015

A new study led by Marka van Blitterswijk from the Mayo Clinic in Jacksonville, Florida found elevated levels of the protein Transthyretin (TTR) in the cerebellum of ALS or frontotemporal dementia (FTD) patients carrying C9ORF72...

The ALS Forum was developed by Prize4Life, Inc.
© 2015 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum